Details for New Drug Application (NDA): 202747
✉ Email this page to a colleague
The generic ingredient in FUROSEMIDE is furosemide. There are twenty-two drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the furosemide profile page.
Summary for 202747
Tradename: | FUROSEMIDE |
Applicant: | Baxter Hlthcare Corp |
Ingredient: | furosemide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 202747
Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for 202747
Suppliers and Packaging for NDA: 202747
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FUROSEMIDE | furosemide | INJECTABLE;INJECTION | 202747 | ANDA | Henry Schein, Inc. | 0404-9862 | 0404-9862-10 | 1 VIAL, GLASS in 1 BAG (0404-9862-10) / 1 mL in 1 VIAL, GLASS |
FUROSEMIDE | furosemide | INJECTABLE;INJECTION | 202747 | ANDA | Henry Schein, Inc. | 0404-9863 | 0404-9863-04 | 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9863-04) / 4 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML | ||||
Approval Date: | Jan 27, 2014 | TE: | AP | RLD: | No |
Complete Access Available with Subscription